Literature DB >> 3928006

The effects of a new opioid analgesic, meptazinol, on the respiration of the conscious rat.

I S Cowlrick, N B Shepperson.   

Abstract

In the conscious rat arterial PCO2 was measured as an index of respiratory status. The opioid analgesic meptazinol (7.5 - 30 mg kg-1) evoked small but significant increases in arterial PCO2 which were attenuated by naloxone. Meptazinol significantly reduced the increase in arterial PCO2 evoked by morphine. The respiratory depression induced by meptazinol, but not that induced by morphine, was enhanced by pretreatment with atropine. The (+)-enantiomer, but not the (-)-enantiomer of meptazinol increased arterial PCO2. In contrast, only the (-)-enantiomer reduced the respiratory depressant effect of morphine. It is proposed that the degree of respiratory depression induced by meptazinol is limited by its opioid antagonist and cholinomimetic properties.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928006      PMCID: PMC1916784          DOI: 10.1111/j.1476-5381.1985.tb08848.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

Review 2.  A review of the biological properties and metabolic disposition of the new analgesic agent, meptazinol.

Authors:  R J Stephens; J F Waterfall; R A Franklin
Journal:  Gen Pharmacol       Date:  1978

3.  Current concepts concerning the mode of action of meptazinol as an analgesic.

Authors:  D Green
Journal:  Postgrad Med J       Date:  1983       Impact factor: 2.401

4.  The analgesic and respiratory effects of meptazinol, morphine and pentazocine in the rat.

Authors:  P G Goode; K F Rhodes; J F Waterfall
Journal:  J Pharm Pharmacol       Date:  1979-11       Impact factor: 3.765

5.  Some properties of WY 22811, a new analgesic compound.

Authors:  P G Goode; A C Shite; D Green
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

6.  Antagonism of the cardiovascular and respiratory depressant effects of morphine in the conscious rabbit by physostigmine.

Authors:  M Weinstock; E Erez; D Roll
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

7.  Meptazinol: a novel Mu-1 selective opioid analgesic.

Authors:  K Spiegel; G W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  1984-02       Impact factor: 4.030

8.  Pharmacological effects of meptazinol and its enantiomers on guinea-pig ileum and mouse vas deferens.

Authors:  R J Duchesne; J Goodall; I E Hughes
Journal:  J Pharm Pharmacol       Date:  1984-08       Impact factor: 3.765

9.  Determination of the relative involvement of mu-opioid receptors in opioid-induced depression of respiratory rate by use of beta-funaltrexamine.

Authors:  S J Ward; A E Takemori
Journal:  Eur J Pharmacol       Date:  1983-01-28       Impact factor: 4.432

10.  The antinociceptive activity of meptazinol depends on both opiate and cholinergic mechanisms.

Authors:  D J Bill; J E Hartley; R J Stephens; A M Thompson
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

View more
  2 in total

1.  Characterization of the effects of (+/-)-meptazinol, its individual enantiomers and N-methyl meptazinol on food consumption in the rat.

Authors:  H C Jackson; R D Sewell
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

Review 2.  Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  B Holmes; A Ward
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.